AI assistant
Sending…
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2008
Sep 29, 2008
33882_dirs_2008-09-29_3d906ffa-c98b-4e43-8d49-088bcdb43370.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2008-09-26
Reporting Person: Cormack Scott Daniel (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-09-26 | Common Stock | P | 3000 | $3.90 | Acquired | 4306 | Direct |
| 2008-09-26 | Common Stock | P | 1500 | $4.20 | Acquired | 5806 | Direct |
| 2008-09-26 | Common Stock | P | 500 | $3.89 | Acquired | 6306 | Direct |
More from ACHIEVE LIFE SCIENCES, INC.
Board/Management Information
2026
Jun 2
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30